Finally, there are no reports of cancer in patients with single-nucleotide variants, but two carriers of 6p22.3 CNVs involving SOX4 developed embryonal tumours; thus, we believe that individuals with such CNVs should be monitored during childhood. The gene discussed is SOX4; the disease is embryonal neoplasm.